New Research Finds New Data-Driven Approaches Would Improve How FDA Monitors Safety of Approved Existing Drugs
October 15, 2021
October 15, 2021
CATONSVILLE, Maryland, Oct. 15 (TNSJou) -- The Institute for Operations Research and the Management Sciences issued the following news release:
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new, robust data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach woul . . .
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new, robust data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach woul . . .